Literature DB >> 23828317

[Clinical results of encapsulated bleb removal after Ahmed glaucoma valve implants].

J Rosbach1, L Choritz, N Pfeiffer, H Thieme.   

Abstract

In refractory glaucoma, surgical intervention is required which in most cases aims at artificially increasing the drainage of aqueous humor from the eye. One surgical option used with increasing frequency is the implantation of episcleral glaucoma drainage devices (GDD). The clinical success of such devices is often limited by excessive wound healing and scar formation around the base plate of the implant. In severe cases, which seem to occur most frequently in pediatric patients, the rapid formation of a thick, water-impervious fibrotic capsule within months after initial implantation leads to diminished aqueous resorption and an increase in intraocular pressure to presurgical values. Often additional surgical interventions become necessary. Excision of the fibrotic tissue around the implant may help to salvage function and might be an alternative to the more commonly practiced implantation of an additional GDD. In the case series presented here the surgical method of capsular revision is described and the clinical outcome in 11 eyes from 10 patients is reported.

Entities:  

Mesh:

Year:  2013        PMID: 23828317     DOI: 10.1007/s00347-013-2836-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  20 in total

1.  Surface topographies of glaucoma drainage devices and their influence on human tenon fibroblast adhesion.

Authors:  Lars Choritz; Kaloian Koynov; Giulia Renieri; Keith Barton; Norbert Pfeiffer; Hagen Thieme
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

2.  Histopathologic findings in early encapsulated blebs of young patients treated with the ahmed glaucoma valve.

Authors:  Hagen Thieme; Lars Choritz; Carmen Hofmann-Rummelt; Ursula Schloetzer-Schrehardt; Ulrike B Kottler
Journal:  J Glaucoma       Date:  2011 Apr-May       Impact factor: 2.503

3.  The Ahmed Versus Baerveldt study: design, baseline patient characteristics, and intraoperative complications.

Authors:  Panos G Christakis; James C Tsai; David Zurakowski; Jeffrey W Kalenak; Louis B Cantor; Iqbal I K Ahmed
Journal:  Ophthalmology       Date:  2011-09-09       Impact factor: 12.079

Review 4.  Surgical management of pediatric glaucoma.

Authors:  Yvonne Ou; Joseph Caprioli
Journal:  Dev Ophthalmol       Date:  2012-04-17

Review 5.  Glaucoma drainage devices: a systematic literature review and current controversies.

Authors:  Chian-Huey Hong; Analisa Arosemena; David Zurakowski; Ramesh S Ayyala
Journal:  Surv Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 6.048

6.  Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation.

Authors:  Anthony C B Molteno; Martin Fucik; Alex G Dempster; Tui H Bevin
Journal:  Ophthalmology       Date:  2003-11       Impact factor: 12.079

7.  The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study.

Authors:  L Cantor; J Burgoyne; S Sanders; V Bhavnani; J Hoop; E Brizendine
Journal:  J Glaucoma       Date:  1998-08       Impact factor: 2.503

8.  The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation.

Authors:  E Kurnaz; A Kubaloglu; Y Yilmaz; A Koytak; Y Ozertürk
Journal:  Eur J Ophthalmol       Date:  2005 Jan-Feb       Impact factor: 2.597

Review 9.  [Glaucoma drainage devices].

Authors:  H Thieme
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

10.  Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.

Authors:  Vital P Costa; Augusto Azuara-Blanco; Peter A Netland; Mark R Lesk; Enyr S Arcieri
Journal:  Ophthalmology       Date:  2004-06       Impact factor: 12.079

View more
  1 in total

1.  Ahmed Glaucoma Valve Implantation for Refractory Glaucoma in a Tertiary Hospital in Brazil.

Authors:  Ricardo Yuji Abe; Carla Melo Tavares; Rui Barroso Schimiti; José Paulo Cabral Vasconcellos; Vital Paulino Costa
Journal:  J Ophthalmol       Date:  2015-05-31       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.